This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción OTIC
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de Otonomy, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0085 |
| 52 Week High | US$2.54 |
| 52 Week Low | US$0.0075 |
| Beta | 1.53 |
| 1 Month Change | -91.98% |
| 3 Month Change | -91.58% |
| 1 Year Change | -99.62% |
| 3 Year Change | -99.60% |
| 5 Year Change | -99.78% |
| Change since IPO | -99.95% |
Noticias y actualizaciones recientes
Recent updates
Otonomy crashes 73% as mid-stage trial for tinnitus candidate fails
Aug 01Otonomy GAAP EPS of -$0.19 beats by $0.01
Jul 25Otonomy: Hearing Loss And Tinnitus Data In 2022
Apr 04Shareholders Will Probably Hold Off On Increasing Otonomy, Inc.'s (NASDAQ:OTIC) CEO Compensation For The Time Being
Jun 16
Otonomy shares rise after initiating expansion of early-stage OTO-413 hearing loss trial
Jun 15Is Otonomy (NASDAQ:OTIC) Using Debt In A Risky Way?
Feb 02Otonomy And Its Efforts At Resurrecting Itself
Jan 12Are Institutions Heavily Invested In Otonomy, Inc.'s (NASDAQ:OTIC) Shares?
Dec 11Otonomy (OTIC) Investor Presentation - Slideshow
Dec 02Otonomy issues update for Otividex and OTO-313
Nov 30Rentabilidad de los accionistas
| OTIC | US Pharmaceuticals | Mercado US | |
|---|---|---|---|
| 7D | -92.6% | 3.0% | 0.3% |
| 1Y | -99.6% | 12.0% | 24.2% |
Rentabilidad vs. Industria: OTIC underperformed the US Pharmaceuticals industry which returned -2.3% over the past year.
Rentabilidad vs. Mercado: OTIC underperformed the US Market which returned -8.9% over the past year.
Volatilidad de los precios
| OTIC volatility | |
|---|---|
| OTIC Average Weekly Movement | 27.8% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: OTIC's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: OTIC's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2008 | 51 | n/a | www.otonomy.com |
Resumen de fundamentos de Otonomy, Inc.
| Estadísticas fundamentales de OTIC | |
|---|---|
| Capitalización bursátil | US$582.48k |
| Beneficios(TTM) | -US$52.26m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está OTIC sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de OTIC | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | US$52.26m |
| Beneficios | -US$52.26m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.76 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 75.4% |
¿Cómo se ha desempeñado OTIC a largo plazo?
Ver rendimiento histórico y comparativa